Company Filing History:
2 out of 47 
1 out of 4,456 
1 out of 47 
Years Active: 2005-2025
Title: **Serge Martinod: Innovator in Vaccine Development**
Introduction
Serge Martinod is an accomplished inventor based in Groton, CT, USA, known for his significant contributions to the field of vaccine development. With a total of four patents to his name, his work focuses on innovative methods and compositions aimed at improving vaccine efficacy and delivery.
Latest Patents
Among his latest patents, Martinod has developed methods related to Hornfly vaccine formulations. These methods involve creating fusion proteins that include a truncated thrombostasin protein that has at least 85% sequence homology to a thrombostasin protein, featuring a carboxy terminal deletion. His patents also disclose vaccine compositions that comprise these thrombostasin proteins, along with methods aimed at inhibiting responses to thrombostasin proteins in hosts requiring such therapeutic interventions. Additionally, he has designed a sustained release vaccine composition that consists of non-liquid vaccine components including one or more antigen components, a pharmaceutically acceptable non-liquid adjuvant, and optionally a non-liquid vaccine protection agent.
Career Highlights
Martinod has had a distinguished career, working with notable corporations such as Virbac Corporation and Pfizer Corporation. His experience at these organizations has greatly contributed to his expertise in the field of immunology and vaccine research, allowing him to innovate and develop groundbreaking solutions.
Collaborations
Throughout his career, Martinod has collaborated with talented individuals in the industry, including Malcolm Brandon and Manuel Campos. These professional relationships have fostered a collaborative environment that encourages the sharing of ideas and innovations in vaccine technology.
Conclusion
Serge Martinod's contributions to vaccine development exemplify his dedication to enhancing public health through science. His innovative approaches and collaborative efforts with leading companies and professionals underscore the importance of continued research and development in the ever-evolving field of immunology. With his patent portfolio, Martinod is a prominent figure driving advancements that could lead to more effective vaccines and therapies.